Robert T. Davis Jr. - Feb 11, 2022 Form 4 Insider Report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Role
EVP & President, TT
Signature
/s/ Eric Schwartz; Attorney-in-Fact
Stock symbol
IART
Transactions as of
Feb 11, 2022
Transactions value $
$0
Form type
4
Date filed
2/14/2022, 03:35 PM
Next filing
Mar 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IART Common Stock Award $0 +2.96K +13.34% $0.00 25.1K Feb 11, 2022 Direct F1
transaction IART Common Stock Award $0 +3.94K +15.68% $0.00 29K Feb 11, 2022 Direct F2
transaction IART Common Stock Award $0 +6.47K +22.26% $0.00 35.5K Feb 11, 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2019 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2022 at 150% of target, the third anniversary of the grant date.
F2 On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2020 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2022 at 150% of target, the second anniversary of the grant date.
F3 On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 12, 2021 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2022 at 200% of target, the first anniversary of the grant date.